Stock option activity for the nine months ended October 31, 2024 was as follows:


	Options Outstanding
	Outstanding Stock Options (in millions)	Weighted- Average Exercise Price		Aggregate Intrinsic Value (in millions)
Balance as of January 31, 2024	12	$	185.77








Exercised	(3)	173.21


Balance as of October 31, 2024	9	$	192.60	$	965
Vested or expected to vest	9	$	192.30	$	952
Exercisable as of October 31, 2024	7	$	181.72	$	762

Restricted stock activity for the nine months ended October 31, 2024 was as follows:


	Restricted Stock Outstanding
	Outstanding (in millions)	Weighted-Average Grant Date Fair Value		Aggregate Intrinsic Value (in millions)
Balance as of January 31, 2024	28	$	202.95
Granted - restricted stock units and awards	11	301.35
Granted - performance-based stock units	1	290.64
Canceled	(2)	223.64
Vested and converted to shares	(10)	201.53
Balance as of October 31, 2024	28	$	245.96	$	8,181
Expected to vest	24			$	7,051

The aggregate expected stock-based compensation expense remaining to be recognized as of October 31, 2024 was as follows (in millions):


Fiscal Period:
Remaining three months of fiscal 2025	$	844
Fiscal 2026	2,536
Fiscal 2027	1,697
Fiscal 2028	1,057
Fiscal 2029	151

Total stock-based compensation expense	$	6,285

The aggregate expected stock-based compensation expense remaining to be recognized reflects only outstanding stock awards as of October 31, 2024 and assumes no forfeiture activity and no changes in the expected level of attainment of performance share grants based on the Company’s financial performance relative to certain targets.

In August 2022, the Board of Directors authorized a program to repurchase up to $10.0 billion of the Company’s common stock (the “Share Repurchase Program”). In February 2023, the Board of Directors authorized an additional $10.0 billion in repurchases under the Share Repurchase Program. In February 2024, the Board of Directors authorized an additional $10.0 billion in repurchases under the Share Repurchase Program for an aggregate total authorization of $30.0 billion. The Share Repurchase Program does not have a fixed expiration date and does not obligate the Company to acquire any specific number of shares. Under the Share Repurchase Program, shares of common stock may be repurchased using a variety of methods, including privately negotiated and or open market transactions, including under plans complying with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as part of accelerated share repurchases and other methods. The timing, manner, price and amount of any repurchases are determined by the Company in its discretion and depend on a variety of factors, including legal requirements, price and economic and market conditions. The Company accounts for treasury stock under the cost method.

The Company repurchased the following under its Share Repurchase Program (in millions, except average price per share):


	2024					2023
	Shares	Average price per share		Amount		Shares	Average price per share		Amount
Three months ended April 30	7	$	293.00	$	2,168	11	$	188.17	$	2,143
Three months ended July 31	18	$	246.14	$	4,288	9	$	211.83	$	1,913
Three months ended October 31	5	$	257.00	$	1,228	9	$	209.33	$	1,924